Blog
-
-
Bristol Myers’ hopes for a CAR-T nod by year-end fade as COVID-19 delays FDA inspection
-
BioNTech to price vaccine below market rates, differentiate between regions
-
String of FDA approvals gives momentum to liquid biopsies
-
FDA advisers vote against Biogen’s Alzheimer’s drug, leaving its future in doubt
-
FDA greenlights Boston Scientific’s paclitaxel-coated Ranger balloon for peripheral artery disease
-
Insurers slam CMS proposal to hasten Medicare coverage of breakthrough medical devices
-
Health care industry has evaded major changes under Trump
-
Sprycel Plus Blincyto Drug Combo May Be Safe, Effective Therapy for Rare Leukemia
-
UMass, CommonSpirit among collection of health systems to form new specialty pharmacy alliance